rubella (German measles, 3rd disease)
Jump to navigation
Jump to search
Etiology
Epidemiology
Clinical manifestations
- postnatal infection
- incubation period is 15-21 days
- prodromal symptoms may precede rash by 1-5 days
- lymphadenopathy
- begins 1-5 days prior to the rash
- suboccipital, postauricular & general
- may be the only sign of infection
- rash appears at the same time as the low-grade fever
- appears 1st on the face, then progresses down the body
- maculopapular rash, discrete often pinpoint lesions occasionally coalescing on the trunk
- duration of rash 3-5 days
- occasional desquamation during convalescence
- petechial lesions on soft palate
- mild conjunctivitis
- fever
- low-grade or absent
- resolves by 1st day of rash
- congenital infection
- manifestations are most severe the earlier in pregnancy the illness occurs
- fetal demise
- premature delivery
- congenital anomalies
- nerve deafness (80-90%)
- growth retardation (50-85%)
- congenital cataracts (35%)[6] (image)
- retinopathy (35%)[6] (image)
- patent ductus arteriosus (30%)
- pulmonary artery &/or valvular stenosis (30%)
- atrial septal defect
- mental retardation (10-20%)
- meningoencephalitis (10-20%)
- behavioral disorders (10-20%)
- hepatosplenomegaly (10-20%)
- bone lesions (10-20%)
- thrombocytopenic purpura (5-10%)
Laboratory
- generally not useful in diagnosing acute disease
- rubella virus antigen in tissue/body fluid
- specimen from nose, throat, urine or other body fluid for diagnosis of congenital infection
- rubella virus serology:
- confounded by false positives
- presence in infant suggests congenital infection
- rubella virus RNA
- see ARUP consult[3]
Complications
(rare)
- arthritis & arthralgia more common in adult women
- thrombocytopenia
- leukopenia
- encephalitis (very rare)
Differential diagnosis
- enteroviral infection
- shorter incubation period (3-7 days)
- more common in younger children
- frequently with higher fever
- seasonal, more common in summer & fall
- measles
- scarlet fever
- infectious mononucleosis
- toxoplasmosis
- roseola
- erythema infectiosum
- drug reactions
Management
- symptomatic treatment for postnatal infection
- pharmacologic agents
- acetaminophen for fever
- aspirin for arthralgia
- prophylaxis:
- MMR vaccine
- immune globulin for susceptible pregnant women with < 20 gestation within 72 hours of exposure (controversial)
- isolation from susceptible individuals until 7 days after the rash
- complete Confidential Morbidity Report; rubella is a reportable disease
More general terms
Additional terms
References
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 868-69
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 1039
- ↑ 3.0 3.1 ARUP Consult: Rubella Virus The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/rubella-virus
- ↑ 4.0 4.1 Papania MJ et al Elimination of Endemic Measles, Rubella, and Congenital Rubella Syndrome From the Western Hemisphere. The US Experience. JAMA Pediatr. Published online December 05, 2013. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24311021 <Internet> http://archpedi.jamanetwork.com/article.aspx?articleid=1787786
Grabowsky M The Beginning of the End of Measles and Rubella. JAMA Pediatr. Published online December 05, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24310954 <Internet> http://archpedi.jamanetwork.com/article.aspx?articleid=1787785
Centers for Disease Control and Prevention Rubella and Congenital Rubella Syndrome Control and Elimination
Global Progress, 2000=2012. MMWR. Weekly. December 6, 2013 / 62(48);983-986 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6248a3.htm - ↑ Pan American Health Organization (PAHO) & World Health Organization (WHO) April 29, 2015 Americas region is declared the world's first to eliminate rubella. http://www.paho.org/hq/index.php?option=com_content&view=article&id=10798%3Aamericas-free-of-rubella&catid=740%3Anews-press-releases&Itemid=1926&lang=en
- ↑ 6.0 6.1 6.2 Matalia J, Shirke S Congenital Rubella N Engl J Med 2016; 375:1468 October 13, 2016 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27732820